EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy

Michel Jadoul iD, Laura Labriola

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14060 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Michel Jadoul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicHepatitis CHumansAntiviral AgentsHepacivirusRenal Dialysis

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

ORCID-Profile: Michel Jadoul

Zitieren

APA

Jadoul, M., & Labriola, L. (2024). Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14060

Vancouver

Jadoul M, Labriola L. Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14060

BibTeX
@article{Jadoul2024,
  author = {Jadoul, Michel and Labriola, Laura},
  title = {Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14060}
}
Kostenlos starten →